(Q40383272)

20 September 2017

1 reference

title

The association between intravenous haloperidol and Torsades de Pointes. Three cases and a literature review (English)

1 reference

20 September 2017

1 reference

Hunt N

1

1 reference

20 September 2017

Stern TA

series ordinal

2

1 reference

20 September 2017

publication date

1 November 1995

1 reference

20 September 2017

1 reference

20 September 2017

volume

36

1 reference

20 September 2017

issue

6

1 reference

20 September 2017

page(s)

541-549

1 reference

Torsade De Pointes, an atypical ventricular tachycardia

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971609-7

7 January 2021

"Les torsades de pointes": an unusual ventricular arrhythmia

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971609-7

7 January 2021

The long QT syndromes: a critical review, new clinical observations and a unifying hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971609-7

7 January 2021

Etiology, warning signs and therapy of torsade de pointes. A study of 10 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971609-7

7 January 2021

Torsades de pointes associated with drugs and toxins: recognition and management

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971609-7

7 January 2021

Doxepin Induced Torsade De Pointes

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971609-7

7 January 2021

Thioridazine (mellaril)-induced ventricular tachycardia controlled with an artificial pacemaker

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971609-7

7 January 2021

Thioridazine-induced torsade de pointes. Successful therapy with isoproterenol

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971609-7

7 January 2021

Q-T prolongation and torsades de pointes ventricular tachycardia produced by the tetracyclic antidepressant agent maprotiline.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971609-7

7 January 2021

Haloperidol and torsades de pointes

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971609-7

7 January 2021

Torsades de pointes ventricular tachyarrhythmia associated with haloperidol.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971609-7

7 January 2021

Haloperidol-induced torsades de pointes

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971609-7

7 January 2021

Life-Threatening Ventricular Arrhythmia (Torsades de Pointes) after Haloperidol Overdose

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971609-7

7 January 2021

QT prolongation and torsades de pointes after administration of trimethoprim-sulfamethoxazole

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971609-7

7 January 2021

REPETITIVE VENTRICULAR ARRHYTHMIA RESULTING FROM ARTIFICIAL INTERNAL PACEMAKER

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971609-7

7 January 2021

Varicella myocarditis presenting with unusual ventricular arrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971609-7

7 January 2021

Liquid protein diets and torsade de pointes

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971609-7

7 January 2021

Cardiac arrhythmia induced by pneumoencephalography

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971609-7

7 January 2021

Torsade de pointes and mitral valve prolapse

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971609-7

7 January 2021

Management of recurrent ventricular tachyarrhythmias associated with Q-T prolongation

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971609-7

7 January 2021

Q-T prolongation and polymorphous ("torsade de pointes") ventricular arrhythmias associated with organophosphorus insecticide poisoning.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971609-7

7 January 2021

Long QT Interval and Ventricular Tachycardia of “Torsade de Pointe” Type in Hypothyroidism

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971609-7

7 January 2021

Hypomagnesemic torsades de pointes

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971609-7

7 January 2021

Torsade de pointes and magnesium deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971609-7

7 January 2021

Polymorphous ventricular tachycardia in acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971609-7

7 January 2021

Torsade de pointes complicating acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971609-7

7 January 2021

Electrocardiographic changes and cardiac arrhythmias in patients receiving psychotropic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971609-7

7 January 2021

CLINICAL OBSERVATIONS OF THE SIDE-EFFECTS OF HALOPERIDOL

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971609-7

7 January 2021

Cardiac arrhythmia and haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971609-7

7 January 2021

Hypotension and cardiopulmonary arrest associated with concurrent haloperidol and propranolol therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971609-7

7 January 2021

Haloperidol and cardiac arrest

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971609-7

7 January 2021

Prolonged Q-T interval and hypokalemia caused by haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971609-7

7 January 2021

The Effect of Haloperidol on Ventricular Fibrillation Threshold in Pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971609-7

7 January 2021

Is hypomagnesemia arrhythmogenic?

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971609-7

7 January 2021

Terfenadine. A review of its pharmacodynamic properties and therapeutic efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971609-7

7 January 2021

Clinical features and basic mechanisms of quinidine-induced arrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971609-7

7 January 2021

10.1016/S0033-3182(95)71609-7

Identifiers

DOI

0 references

1 reference